Found: 19
Select item for more details and to access through your institution.
Breaking New Ground in the Treatment of Advanced Endometrial Cancer.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 6, p. 239
- By:
- Publication type:
- Article
Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab.
- Published in:
- Oncologist, 2024, v. 29, n. 1, p. 25, doi. 10.1093/oncolo/oyad201
- By:
- Publication type:
- Article
Characterization and Management of Adverse Reactions in Patients with Advanced Endometrial Carcinoma Treated with Lenvatinib Plus Pembrolizumab.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1599, doi. 10.1002/onco.13883
- By:
- Publication type:
- Article
Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 1, p. 183, doi. 10.1007/s00262-022-03225-1
- By:
- Publication type:
- Article
Survival of Patients with Serous Uterine Carcinoma Undergoing Sentinel Lymph Node Mapping.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2017, v. 24, n. 7, p. 1965, doi. 10.1245/s10434-017-5816-4
- By:
- Publication type:
- Article
Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node Mapping.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2016, v. 23, n. 1, p. 196, doi. 10.1245/s10434-015-4612-2
- By:
- Publication type:
- Article
Impact of obesity and white adipose tissue inflammation on the omental microenvironment in endometrial cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Decreased HER2 expression in endometrial cancer following anti‐HER2 therapy.
- Published in:
- Journal of Pathology, 2024, v. 262, n. 2, p. 129, doi. 10.1002/path.6230
- By:
- Publication type:
- Article
A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 6, p. 742, doi. 10.1007/s10637-017-0445-0
- By:
- Publication type:
- Article
Lenvatinib plus pembrolizumab in Japanese patients with endometrial cancer: Results from Study 309/KEYNOTE‐775.
- Published in:
- Cancer Science, 2022, v. 113, n. 10, p. 3489, doi. 10.1111/cas.15436
- By:
- Publication type:
- Article
Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival.
- Published in:
- Radiation Oncology, 2013, v. 8, n. 1, p. 1, doi. 10.1186/1748-717X-8-36
- By:
- Publication type:
- Article
Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancers.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-72475-9
- By:
- Publication type:
- Article
Characterization and Management of Adverse Reactions in Patients with Endometrial Carcinoma Receiving Lenvatinib plus Pembrolizumab (Study 111/KEYNOTE-146): Nurse Roles in Patient Education and Adverse-Reaction Management.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2020, v. 11, n. 11, p. 439
- By:
- Publication type:
- Article
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e40
- By:
- Publication type:
- Article
Phase II, 2‐stage, 2‐arm, PIK3CA mutation stratified trial of MK‐2206 in recurrent endometrial cancer.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 2, p. 413, doi. 10.1002/ijc.32783
- By:
- Publication type:
- Article